PROCEPT BioRobotics Corporation Common Stock
PRCT
$23.22
-9.67%
PRCT
PROCEPT BioRobotics Corporation Common Stock
$23.22
Related headlines
PRCT price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on PROCEPT BioRobotics Corporation Common Stock's 12-month outlook, with a consensus price target around $30.19 and implied upside of +30.0% versus the current price.
Average Target
$30.19
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$19 - $30
Analyst target range
PRCT Technical Analysis
Beta
0.85
0.85x market volatility
Max Drawdown
-66.6%
Largest decline past year
52-Week Range
$19-$62
Price range past year
Annual Return
-61.7%
Cumulative gain past year
| Period | PRCT Return | S&P 500 |
|---|---|---|
| 1m | -11.1% | +2.1% |
| 3m | -15.1% | +12.5% |
| 6m | -31.3% | +12.4% |
| 1y | -61.7% | +26.4% |
| ytd | -24.5% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is PRCT Overvalued?
PE
-18.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-17.7x
Enterprise Value Multiple
